Charts Relmada Therapeutics, Inc. OTC Markets
Stocks
RLMD
US75955J4022
Biotechnology & Medical Research
|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
+8.91% | +139.13% |
| 08-06 | Relmada Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Relmada Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Stock exchange
OTC Markets
RLMD - $
-.--%
0
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| RLMD | 4.540USD | +1.79% | 6.43M $ | |
CBOE
| RLMD | 4.550USD | +1.79% | 198K $ | |
|
Börse Stuttgart
| 4E2 | 3.820EUR | +0.53% | 0 € | |
|
Deutsche Boerse AG
| 4E2 | 3.720EUR | +2.20% | 0 € | |
|
Tradegate
| 4E2 | 3.920EUR | +1.55% | 0 € | |
|
Boerse Muenchen
| 4E2 | 3.880EUR | +1.04% | 0 € |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RLMD Stock
- RLMD Stock
- Charts Relmada Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
